Avid Radiopharmaceuticals

Acquired

Avid Radiopharmaceuticals was founded in 2005, is headquartered in Philadelphia, United States, lists 51–200 employees, and has $69.9M in recorded funding across 4 rounds.

Employees
51–200
Founded
2005
Business Model
B2B
Website
avidrp.com
Total Funding
$69.9M
Last Round
$34.5M Series DMay 2009
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Avid Radiopharmaceuticals is a Philadelphia-based molecular imaging company founded in 2005 and acquired by Eli Lilly in 2010, operating as a wholly-owned subsidiary. The company's mission is to discover, develop, and deliver diagnostic solutions that improve global health by accelerating the development of new medicines. Avid is best known for developing Amyvid (florbetapir F 18 injection), the first FDA-approved PET imaging agent for detecting amyloid plaques associated with Alzheimer's disease. Based at the University City Science Center research campus in Philadelphia, the company focuses on radiopharmaceutical diagnostics to advance neuroscience and other disease areas.

Summary

Avid Radiopharmaceuticals is a Biotech company based in Philadelphia, United States, founded in 2005. It lists 51–200 employees. It has raised $69.9M in total across 4 rounds, most recently a $34.5M Series D round in May 2009. Investors include Alta Partners, Pfizer Ventures and Eli Lilly.

Funding & Exit History

Series DSeries DMay 2009
$34.5M

Sign up to see all 5 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avid Radiopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/avid-radiopharmaceuticals"><img src="https://indexed.vc/api/badge/company/avid-radiopharmaceuticals" alt="Avid Radiopharmaceuticals on Indexed.vc" width="260" height="76" /></a>